Skip to main content
Clinical Trials/CTRI/2020/10/028328
CTRI/2020/10/028328
Not Yet Recruiting
Phase 2

Gait training with Exoskeletal Robot in patients with incompletespinal cord injury and its effect on locomotion: A prospective pre-post study

International Institute of Information Technology Bengaluru0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
International Institute of Information Technology Bengaluru
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
International Institute of Information Technology Bengaluru

Eligibility Criteria

Inclusion Criteria

  • 1\. Men and women with Spinal Cord Injury (SCI) aged between 18 \- 60 years with
  • paraplegia or tetraplegia, sub\-acute or chronic ( \> 3 week after the injury).
  • Non\-traumatic SCI will also be included, given they have neurologically stable
  • conditions.
  • 2\. Sufficient diaphragmatic strength (\>\= 30 single breath count) such that respiration is not compromised with exercise.
  • 3\. AIS\-C SCI \& AIS\-D SCI (motor incomplete), as determined by the International Standards for Neurological Classification of SCI (ISNCSCI).
  • 4\. No history of other neurological conditions.
  • 5\. Weight 90kg or less.
  • 6\. Be able to fit into the REARS device.
  • 7\. Height between approximately 5 feet and 6 feet

Exclusion Criteria

  • 1\. AIS\-A \& AIS\-B spinal cord injury patients
  • 2\. Lower motor neuron injuries
  • 3\. Currently involved in another interventional study
  • 4\. DEXA results indicating a t\-score below \-2\.5 at the lumbar spine and proximal femur
  • 5\. Uncontrolled or severe orthostatic hypotension that limits standing tolerance; defined as sustained, symptomatic drops in systolic and diastolic (\>\= 20 mm Hg systolic, \>\= 10 mm Hg diastolic) blood pressure when moving from sitting to standing
  • 6\. Active heterotopic ossification (HO)
  • 7\. Contractures at the hip or knee preventing standing, hip dysplasia or hip / knee axis abnormalities
  • 8\. Unresolved deep vein thrombosis
  • 9\. Uncontrolled autonomic dysreflexia
  • 10\. Severe muscular or skeletal pain.

Outcomes

Primary Outcomes

Not specified

Similar Trials